SMTL ID : 3o5x.1

Crystal structure of the oncogenic tyrosine phosphatase SHP2 complexed with a salicylic acid-based small molecule inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x JZG: 3-{1-[3-(biphenyl-4-ylamino)-3-oxopropyl]-1H-1,2,3-triazol-4-yl}-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid(Non-covalent)

JZG.1: 9 residues within 4Å: Chain A: Y.19, R.102, K.104, W.163, C.199, G.204, R.205, Q.246, Q.250 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:R.102, A:K.104 Hydrogen bonds: A:R.205, A:Q.250 Water bridges: A:S.200, A:G.202, A:Q.246 Salt bridges: A:K.106, A:R.205 pi-Cation interactions: A:K.106

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, X. et al., Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). J.Med.Chem. (2010)

Release Date

2010-08-11

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 11

Related Entries With Identical Sequence